Abstract
Studies on the molecular mechanisms behind soft tissue sarcoma development have disclosed that these malignancies are as genetically heterogeneous as they are clinically and morphologically diverse. Much of the genetic information on soft tissue sarcomas is still limited to the genomic level, as detected by chromosome banding analysis or comparative genomic hybridization. Based on the results of such studies, soft tissue sarcomas may be broadly dichotomized into one group, accounting for approximately 20% of the cases, characterized by specific balanced translocations, and one group typically showing massive chromosomal rearrangements leading to recurrent, but non-specific, structural and numerical rearrangements. As summarized in this review, the genomic characterization of soft tissue sarcomas has not only provided cell biologists with decisive information on the parts of the genome that may harbor genes that are essential for tumor development but also given the clinicians involved in the management of these patients a valuable diagnostic tool.
Similar content being viewed by others
References
Boveri T (1914) Zur Frage der Entstehung maligner Tumoren. Gustav Fisher Verlag, Jena
Mitelman F, Johansson B, Mertens F (2007) The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 7:233–245
Mitelman F, Johansson B, Mertens F (Eds) (2008) Mitelman database of chromosome aberrations in cancer. http://cgap.nci.nih.gov/Chromosomes/Mitelman
Pinkel D, Albertson DG (2005) Array comparative genomic hybridization and its application in cancer. Nat Genet 37:S11–S17
Fletcher CDM, Unni KK, Mertens F (eds) (2002) World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. IARC, Lyon
Helman LJ, Meltzer P (2003) Mechanisms of sarcoma development. Nat Rev Cancer 3:685–694
Billing V, Mertens F, Domanski HD et al (2008) Deep-seated ordinary and atypical lipomas; histopathology, cytogenetics, clinical features, and outcome in 215 tumors of the extremity and trunk wall. J Bone Joint Surg Br 90:929–933
Berner J-M, Forus A, Elkahloun A et al (1996) Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas. Genes Chromosomes Cancer 17:254–259
Dei Tos AP, Doglioni C, Piccinin S et al (2000) Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumors. J Pathol 190:531–536
Hostein I, Pelmus M, Aurias A et al (2004) Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin wax-embedded material: a potential tool for the diagnosis of atypical lipomatous tumours/well-differentiated liposarcomas. J Pathol 202:95–102
Italiano A, Bianchini L, Keslair F et al (2008) HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon. Int J Cancer 122:2233–2241
Singer S, Socci ND, Ambrosini G et al (2007) Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma. Cancer Res 67:6626–6636
Meza-Zepeda LA, Forus A, Lygren BO et al (2002) Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21. Oncogene 21:2261–2269
Micci F, Teixeira MR, Bjerkehagen B et al (2002) Characterization of supernumerary rings and giant marker chromosomes in well-differentiated lipomatous tumors by a combination of G-banding, CGH, M-FISH, and chromosome- and locus-specific FISH. Cytogenet Genome Res 97:13–19
Nilsson M, Meza-Zepeda LA, Mertens F et al (2004) Amplification of chromosome 1 sequences in lipomatous tumors and other sarcomas. Int J Cancer 109:363–369
Pedeutour F, Forus A, Coindre J-M et al (1999) Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer 24:30–41
Coindre J-M, Hostein I, Maire G et al (2004) Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity. J Pathol 203:822–830
Rieker RJ, Joos S, Bartsch C et al (2002) Distinct chromosomal imbalances in pleomorphic and in high-grade dedifferentiated liposarcomas. Int J Cancer 99:68–73
Turc-Carel C, Limon J, Dal Cin P et al (1986) Cytogenetic studies of adipose tissue tumors. II. Recurrent reciprocal translocation t(12;16)(q13;p11) in myxoid liposarcomas. Cancer Genet Cytogenet 23:291–299
Crozat A, Åman P, Mandahl N et al (1993) Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363:640–644
Rabbitts TH, Forster A, Larson R et al (1993) Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat Genet 4:175–180
Panagopoulos I, Höglund M, Mertens F et al (1996) Fusion of the EWS and CHOP genes in myxoid liposarcoma. Oncogene 12:489–494
Idbaih A, Coindre J-M, Derré J et al (2005) Myxoid malignant fibrous histiocytoma and pleomorphic liposarcoma share very similar genomic imbalances. Lab Invest 85:176–181
Dahlén A, Fletcher CDM, Mertens F et al (2004) Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12). Am J Pathol 164:1645–1653
Miettinen MM, el-Rifai W, Sarlomo-Rikala M et al (1997) Tumor size-related DNA copy number changes occur in solitary fibrous tumors but not in hemangiopericytomas. Mod Pathol 10:1194–1200
Griffin CA, Hawkins AL, Dvorak C et al (1999) Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors. Cancer Res 59:2776–2780
Lawrence B, Perez-Atayde A, Hibbard MK et al (2000) TPM3–ALK and TPM4–ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol 157:377–384
Patel AS, Murphy KM, Hawkins AL et al (2007) RANBP2 and CLTC are involved in ALK rearrangements in inflammatory myofibroblastic tumors. Cancer Genet Cytogenet 176:107–114
Knezevich SR, McFadden DE, Tao W et al (1998) A novel ETV6–NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 18:184–187
Rubin BP, Chen C-J, Morgan TW et al (1998) Congenital mesoblastic nephroma t(12;15) is associated with ETV6–NTRK3 gene fusion. Cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am J Pathol 153:1451–1458
Mertens F, Fletcher CDM, Dal Cin P et al (1998) Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Genes Chromosomes Cancer 22:16–25
Örndal C, Rydholm A, Willén H et al (1994) Cytogenetic intratumor heterogeneity in soft tissue tumors. Cancer Genet Cytogenet 78:127–137
Willems SM, Debiec-Rychter M, Szuhai K et al (2006) Local recurrence of myxofibrosarcoma is associated with increase in tumor grade and cytogenetic aberrations, suggesting a multistep tumour progression model. Mod Pathol 19:407–416
Ohguri T, Hisaoka M, Kawauchi S et al (2006) Cytogenetic analysis of myxoid liposarcoma and myxofibrosarcoma by array-based comparative genomic hybridisation. J Clin Pathol 59:978–983
Wettach GR, Boyd LJ, Lawce HJ et al (2008) Cytogenetic analysis of a hemosiderotic fibrolipomatous tumor. Cancer Genet Cytogenet 182:140–143
Panagopoulos I, Storlazzi CT, Fletcher CDM et al (2004) The chimeric FUS/CREB3L2 gene is specific for low-grade fibromyxoid sarcoma. Genes Chromosomes Cancer 40:218–228
Guillou L, Benhattar J, Gengler C et al (2007) Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma. A study from the French sarcoma group. Am J Surg Pathol 31:1387–1402
Mertens F, Fletcher CDM, Antonescu CR et al (2005) Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene. Lab Invest 85:408–415
Matsuyama A, Hisaoka M, Shimajiri S et al (2006) Molecular detection of FUS–CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens. Am J Surg Pathol 30:1077–1084
Mandahl N, Heim S, Willén H et al (1990) Supernumerary ring chromosome as the sole cytogenetic abnormality in a dermatofibrosarcoma protuberans. Cancer Genet Cytogenet 49:273–275
Pedeutour F, Coindre J-M, Sozzi G et al (1994) Supernumerary ring chromosomes containing chromosome 17 sequences. A specific feature of dermatofibrosarcoma protuberans? Cancer Genet Cytogenet 76:1–9
O’Brien KP, Seroussi E, Dal Cin P et al (1998) Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas. Genes Chromosomes Cancer 23:187–193
Simon M-P, Pedeutour F, Sirvent N et al (1997) Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat Genet 15:95–98
Patel UK, Szabo SS, Hernandez VS et al (2008) Dermatofibrosarcoma protuberans COL1A1–PDGFB fusion is identified in virtually all dermatofibrosarcoma cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays. Hum Pathol 39:184–193
Kiuru-Kuhlefelt S, El-Rifai W, Fanburg-Smith J et al (2001) Concomitant DNA copy number amplification at 17q and 22q in dermatofibrosarcoma protuberans. Cytogenet Cell Genet 92:192–195
Abbott JJ, Erickson-Johnson M, Wang X et al (2006) Gains of COL1A1–PDGFB genomic copies occur in fibrosarcomatous transformation of dermatofibrosarcoma protuberans. Mod Pathol 19:1512–1518
Fletcher CDM, Gustafson P, Rydholm A et al (2001) Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J Clin Oncol 19:3045–3050
Chibon F, Mariani O, Derré J et al (2002) A subgroup of malignant fibrous histiocytomas is associated with genetic changes similar to those of well-differentiated liposarcomas. Cancer Genet Cytogenet 139:24–29
Nakayama R, Nemoto T, Takahashi H et al (2007) Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma. Mod Pathol 20:749–759
Simons A, Schepens M, Jeuken J et al (2000) Frequent loss of 9p21 (p16INK4A) and other genomic imbalances in human malignant fibrous histiocytoma. Cancer Genet Cytogenet 118:89–98
Mandahl N, Fletcher CDM, Dal Cin P et al (2000) Comparative cytogenetic study of spindle cell and pleomorphic leiomyosarcomas of soft tissues: a report from the CHAMP Study Group. Cancer Genet Cytogenet 116:66–73
Wang R, Lu Y-J, Fisher C et al (2001) Characterization of chromosome aberrations associated with soft-tissue leiomyosarcomas by twenty-four-color karyotyping and comparative genomic hybridization analysis. Genes Chromosomes Cancer 31:54–64
Chang A, Schuetze SM, Conrad EU III et al (2005) So-called “inflammatory leiomyosarcoma”: a series of 3 cases providing additional insights into a rare entity. Int J Surg Pathol 13:185–195
Larramendy ML, Kaur S, Svarvar C et al (2006) Gene copy number profiling of soft-tissue leiomyosarcomas by array-comparative genomic hybridization. Cancer Genet Cytogenet 169:94–101
Meza-Zepeda LA, Kresse SH, Barragan-Polania AH et al (2006) Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas. Cancer Res 66:8984–8993
Hu J, Rao UNM, Jasani S et al (2005) Loss of DNA copy number of 10q is associated with aggressive behavior of leiomyosarcomas: a comparative genomic hybridization study. Cancer Genet Cytogenet 161:20–27
Wang R, Titley JC, Lu Y-J et al (2003) Loss of 13q14-q21 and gain of 5p14-pter in the progression of leiomyosarcoma. Mod Pathol 16:778–785
Douglass EC, Shapiro DN, Valentine M et al (1993) Alveolar rhabdomyosarcoma with the t(2;13): cytogenetic findings and clinicopathologic correlations. Med Pediatr Oncol 21:83–87
Gordon T, McManus A, Anderson J et al (2001) Cytogenetic abnormalities in 42 rhabdomyosarcoma: a United Kingdom Cancer Cytogenetics Group study. Med Pediatr Oncol 36:259–267
Xia SJ, Pressey JG, Barr FG (2002) Molecular pathology of rhabdomyosarcoma. Cancer Biol Therapy 1:97–104
Barr FG (2001) Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma. Oncogene 20:5736–5746
Barr FG, Qualman SJ, Macris MH et al (2002) Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions. Cancer Res 62:4704–4710
Davicioni E, Finckenstein FG, Shahbazian V et al (2006) Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas. Cancer Res 66:6936–6946
Wachtel M, Dettling M, Koscielniak E et al (2004) Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1. Cancer Res 64:5539–5545
Sorensen PHB, Lynch JC, Qualman SJ et al (2002) PAX3–FKHR and PAX7–FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the Children’s Oncology Group. J Clin Oncol 20:2672–2679
Kullendorff CM, Donnér M, Mertens F et al (1998) Chromosomal aberrations in a consecutive series of childhood rhabdomyosarcoma. Med Pediatr Oncol 30:156–159
Bridge JA, Liu J, Weibolt V et al (2000) Novel genomic imbalances in embryonal rhabdomyosacoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: an intergroup rhabdomyosarcoma study. Genes Chromosomes Cancer 27:337–344
Baumhoer D, Gunawan B, Becker H et al (2005) Comparative genomic hybridization in four angiosarcomas of the breast. Gynecol Oncol 97:348–352
Bottillo I, Ahlquist T, Brekke H et al (2008) Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours. J Pathol, in press
Berner J-M, Sorlie T, Mertens F et al (1999) Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumours: studies of CDKN2A and other genes of the pRB pathway. Genes Chromosomes Cancer 26:151–160
Bridge RS Jr, Bridge JA, Neff JR et al (2004) Recurrent chromosomal imbalances and structurally abnormal breakpoints within complex karyotypes of malignant peripheral nerve sheath tumour and malignant triton tumour: a cytogenetic and molecular cytogenetic study. J Clin Pathol 57:1172–1178
Jhanwar SC, Chen Q, Li FP et al (1994) Cytogenetic analysis of soft tissue sarcomas. Recurrent chromosome abnormalities in malignant peripheral nerve sheath tumors (MPNST). Cancer Genet Cytogenet 78:138–144
Mantripragada KK, Spurlock G, Kluwe L et al (2008) High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization. Clin Cancer Res 14:1015–1024
Mertens F, Dal Cin P, De Wever I et al (2000) Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP Study Group. J Pathol 190:31–38
Storlazzi CT, Brekke HR, Mandahl N et al (2006) Identification of a novel amplicon at distal 17q containing the BIRC5/SURVIVIN gene in malignant peripheral nerve sheath tumours. J Pathol 209:492–500
Antonescu CR, Dal Cin P, Nafa K et al (2007) EWSR1–CREB is the predominant gene fusion in angiomatoid fibrous histiocytoma. Genes Chromosomes Cancer 46:1051–1060
Hallor KH, Micci F, Meis-Kindblom JM et al (2007) Fusion genes in angiomatoid fibrous histiocytoma. Cancer Lett 251:158–163
Limon J, Mrozek K, Mandahl N et al (1991) Cytogenetics of synovial sarcoma: presentation of ten new cases and review of the literature. Genes Chromosomes Cancer 3:338–345
Mandahl N, Limon J, Mertens F et al (1995) Nonrandom secondary chromosome aberrations in synovial sarcomas with t(X;18). Int J Oncol 7:495–499
Panagopoulos I, Mertens F, Isaksson M et al (2001) Clinical impact of molecular and cytogenetic findings in synovial sarcoma. Genes Chromosomes Cancer 31:362–372
Turc-Carel C, Dal Cin P, Limon J et al (1987) Involvement of chromosome X in primary cytogenetic change in human neoplasia: nonrandom translocation in synovial sarcoma. Proc Natl Acad Sci USA 84:1981–1985
Ladanyi M, Antonescu CR, Leung DH et al (2002) Impact of SYT–SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res 62:135–140
Guillou L, Benhattar J, Binichon F et al (2004) Histologic grade, but not SYT–SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis. J Clin Oncol 22:4040–4050
Amary MFC, Berisha F, Del Carlo Bernardi F et al (2007) Detection of SS18–SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma. Mod Pathol 20:482–496
Bridge JA, Borek DA, Neff JR et al (1990) Chromosomal abnormalities in clear cell sarcoma. Implications for histogenesis. Am J Clin Pathol 93:26–31
Panagopoulos I, Mertens F, Debiec-Rychter M et al (2002) Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of the tendons and aponeuroses. Int J Cancer 99:560–567
Antonescu CR, Nafa K, Segal NH et al (2006) EWS–CREB1: a recurrent variant fusion in clear cell sarcoma—association with gastrointestinal location and absence of melanocytic differentiation. Clin Cancer Res 12:5356–5362
Gerald WL, Haber DA (2005) The EWS–WT1 gene fusion in desmoplastic small round cell tumor. Semin Cancer Biol 15:197–205
Lae ME, Roche PC, Jin L et al (2002) Desmoplastic small round cell tumor. A clinicopathologic, immunohistochemical, and molecular study of 32 tumors. Am J Surg Pathol 26:823–835
Lualdi E, Modena P, Debiec-Rychter M et al (2004) Molecular cytogenetic characterization of proximal-type epithelioid sarcoma. Genes Chromosomes Cancer 41:283–290
Modena P, Lualdi E, Facchinetti F et al (2005) SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. Cancer Res 65:4012–4019
Panagopoulos I, Mertens F, Isaksson M et al (2002) Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma. Genes Chromosomes Cancer 35:340–352
Sjögren H, Meis-Kindblom JM, Örndal C et al (2003) Studies on the molecular pathogenesis of extraskeletal myxoid chondrosarcoma—cytogenetic, molecular genetic, and cDNA microarray analyses. Am J Pathol 162:781–792
Hisaoka M, Hashimoto H (2005) Extraskeletal myxoid chondrosarcoma: updated clinicopathological and molecular genetic characteristics. Pathol Int 55:453–463
Ladanyi M, Lui MY, Antonescu CR et al (2001) The der(17) t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene 20:48–57
Folpe AL, Deyrup AT (2006) Alveolar soft-part sarcoma: a review and update. J Clin Pathol 59:1127–1132
Mertens F, Strömberg U, Rydholm A et al (2006) Prognostic significance of chromosome aberrations in high-grade soft tissue sarcomas. J Clin Oncol 24:315–320
Acknowledgments
The authors are supported by grants from the Swedish Cancer Society, the Swedish Children’s Cancer Fund, and the Swedish Research Council.
Conflicts of interest
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mertens, F., Panagopoulos, I. & Mandahl, N. Genomic characteristics of soft tissue sarcomas. Virchows Arch 456, 129–139 (2010). https://doi.org/10.1007/s00428-009-0736-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-009-0736-8